Written by 4:33 am Covid19 Views: 6

UK approves Pfizer, becomes the first country to roll out Covid-19 vaccine

Coronavirus Vaccine, U.K. Government, Pharma Company, Vaccine

By Administrator_India

capital Sands

Britain will be the first country in the West to roll out a Covid-19 vaccine, beating the United States and Europe in a race to control the pandemic that has left close to 1.5 million dead globally. UK’s drug authority—Medicines and Healthcare products Regulatory Agency (MHRA)–on Wednesday granted an emergency licence to the antidote developed by American pharma major Pfizer along with Germany’s BioNTech, inspiring confidence in people and economies around the world after a year of extreme pain and losses.

With 800,000 doses expected to be delivered over the next few days, inoculations will begin next week. The MHRA head, Dr June Raine, has given an assurance that “no corners have been cut” in the process. Elaborating on the safety aspects, the Department of Health and Social Care said the licence was granted after months of rigorous clinical trials and a thorough analysis of the data by experts at the MHRA who have concluded that the vaccine has met its strict standards of safety, quality and effectiveness.

While the UK government’s announcement went viral, Russian President Vladimir Putin told his health officials to begin widespread vaccinations next week. According to Putin, Russia has produced around 2 million doses of Sputnik vaccine so far.

But, health secretary Matt Hancock admitted the task of handling the BioNTech-Pfizer vaccine will be “challenging”. It has to be preserved at minus 70C degree temperature. Most general practitioner surgeries would not thus be able to administer it. A network of 50 hospitals and specially built vaccination centres will be entrusted to provide the injections.

Pfizer, which is exporting its vaccine from a plant in Belgium, will place 4 million doses at the disposal of the National Health Service this month and 40 million by the end of March.

Although work on its indigenous Oxford University vaccine, which could be available in India during the first quarter of 2021, was promising, the Johnson government took a punt on the BioNTech research as well. The move has paid off, according to officials.

The Oxford vaccine, on the other hand, is based on ChAdOx1 technology, which has been used as candidates to combat the common flu, Zika and MERS. It is a chimpanzee adenovirus vaccine vector. The University claimed, “ChAdOx1 was chosen as the most suitable vaccine technology for a SARS-CoV-2 vaccine.”

Covid-19 is seen as the biggest pandemic after about 100 years of the deadly Spanish Flu that killed an estimated 50 million.

From the end of 2019, when Covid cases were diagnosed in the Chinese city of Wuhan, the virus has spread across the globe. John Hopkins University of Medicine, which has been monitoring the infection, has put the global cases at nearly 7 million and a death toll of 1.48 million. The US tops the mortality list, followed by Brazil and India.

The United Kingdom has recorded almost 1.65 million positive tests and more than 59,000 deaths. However, transiting out of its membership of the European Union has enabled the UK’s MHRA to fast track an emergency approval.

(Visited 6 times, 1 visits today)